Skip to content

Advertisement

  • Research note
  • Open Access

Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria

BMC Research Notes201710:721

https://doi.org/10.1186/s13104-017-3051-5

  • Received: 20 October 2017
  • Accepted: 30 November 2017
  • Published:

Abstract

Objectives

Though iron deficiency is known to be a major risk factor of anaemia, the association of G6PD deficiency and malaria with anaemia still remains unclear. Hence, a cross-sectional study involving 95 pregnant women visiting Prime Care Hospital in Trans-Ekulu region of Enugu Nigeria was conducted to determine possible predictors of anaemia in pregnancy.

Results

The prevalence of anaemia, malaria and G6PD deficiency were 53.7, 12.6 and 60% respectively. Low serum ferritin (OR 5.500, CI 2.25–13.42, p < 0.05) and G6PD deficiency (OR 0.087, CI 0.03–0.23, p < 0.05) were associated with anaemia in pregnancy. On the other hand, malaria did not significantly associate (OR 1.184, CI 0.35–3.97, p = 0.964) with anaemia in pregnant women. These findings showed high prevalence of anaemia among pregnant women with low serum ferritin level and G6PD deficiency as high risk factors of anaemia.

Keywords

  • Anaemia
  • Malaria
  • Pregnancy
  • G6PD deficiency
  • Serum ferritin
  • Haemoglobin concentration

Introduction

Globally, anaemia affects about 2 billion people of which over 800 million are children and pregnant women particularly in Africa and Asia [1, 2]. Of the estimated 1 million yearly deaths in Africa and South-East Asia, anaemia is reported to account for about 75% [3]. Anaemia in pregnancy is even more prominent in developing countries with an estimated prevalence ranging from about 56 to 61% [4]. It is estimated to be responsible for about 20% of maternal death in sub-Sahara Africa [5].

Anaemia is characterized by low haemoglobin (Hb) concentration in blood below the normal level [6]. Iron is a major and essential component of Hb affix in the porphyrin ring mainly to bind oxygen molecules thereby facilitating its distribution in the body which is required for cellular respiration and other cell functions [7]. Iron is stored in the form of ferritin which is an intracellular protein containing about 4000–4500 iron atoms, thus serves as iron store in the body [8]. Low serum ferritin level in the body has been shown to be associated with iron deficiency and eventually anaemia [9]. Apart from iron level and serum ferritin in blood, glucose 6 phosphate dehydrogenase (G6PD) deficiency [10] and malaria [11] are other factors of concern. Deficiency of G6PD enzyme results in decrease level of reduced glutathione (GSH) thus making the red blood cells (RBCs) vulnerable to oxidative damage and eventually haemolysis or anaemia [12]. Malaria during pregnancy is among the most common complications of pregnancy and highly prevalent in sub-Sahara Africa [13]. In malaria-endemic areas, especially sub-Sahara Africa, about 25% of pregnant women are estimated to be infected with malaria parasite [14]. Though most malaria infections in pregnant women may be asymptomatic, the resultant anaemia may be fatal [15] constituting a major risk of anaemia in pregnancy.

Though serum ferritin and malaria are well documented as potential risk factors of anaemia in pregnancy, limited data is available on the contribution of G6PD deficiency with other predictors of anaemia in pregnancy.

Main text

Methods

Study area/participants

This pilot study was carried out among pregnant women attending anti-natal care (ANC) at Prime Care hospital, Trans-Ekulu, Enugu, Nigeria. Prime care hospital is located in Enugu East local government area of Enugu with coordinates: 6°27′9.60″N 7°30′37.20″E.

Study design and inclusion criteria

This cross sectional study involved pregnant women of all trimester visiting ANC from April to May, 2015 who had not received any therapy for anaemia or iron supplement, not severely ill, no complications and are willing to participate were considered for inclusion and consecutively recruited for the study.

Sample collection and analysis

Five millilitre of venous blood was collected into EDTA tubes to estimate the Hb level, pack cell volume (PCV), RBC count, and mean cell haemoglobin (MCV) using haematological analyser CELL DYN 1800, Abott Laboratories Diagnostic Division, USA. Thin and thick blood films were prepared, incubated with 10% Giemsa stain by Sigma-Aldrich Germany for 10 min then examined microscopically for the presence of malaria parasite using Model 3000FF microscope by Fisher Scientific, USA. Serum ferritin level was determined according to the method of Worwood and collaborators [16]. The methaemoglobin reduction test of Brewer et al. [17] was used for the determination of G6PD deficiency.

Data and statistical analysis

Anaemia in pregnancy was defined as Hb less than 11 g/dL and further classified as mild, moderate, and severe anaemia with Hb measurement between 10.0 and 10.9 g/dL, 7.0 and 9.9 g/dL and less than 7.0 g/dL respectively. For the MCV, anaemia was defined as < 80 fL/cell while no anaemia or normal ≥80 fL/cell. A PCV of less than 30% was considered as anaemia while a PCV greater than or equal to 30% was considered normal. RBC count of less than 3.2 million/mm3 was defined as anaemia and above 3.2 million/mm3 was considered normal. Anaemia as defined by serum ferritin was considered at less than 30 μg/L while above 30 μg/L was normal.

The data was analysed using statistical package for social sciences (SPSS) version 16 and presented in tables. Frequencies and proportions of categorical variables were compared with Chi square tests for association. Predictive factors of anaemia were considered as the independent variables and anaemia as the dependent variable to determine the correlation coefficient (r) and significance by Pearson correlation. Logistic regression was employed to determine the odd ratio (OR of the various predictive factors of anaemia. Confidence interval (CI) was taken at 95% and significant differences were considered at p ≤ 0.05.

Results

Baseline characteristics of pregnant women

As shown in Table 1, 95 pregnant women enrolled in the study among which 37 (38.9%) were in their first trimester, 35 (36.8%) in their second trimester and 23 (24.2%) in their third trimester. Their ages ranged from 20 to 35 years with a mean of 27.33 ± 4.21 years while the most frequent age was 30 years. The Hb level of the women ranged from 5.5 to 13.5 g/dL with a mean of 9.9 ± 2.04 g/dL.
Table 1

Baseline characteristics of the study

Parameters

Age (years)

Hb (g/dL)

PCV (%)

RBC (million/mm3)

MCV (fL/cell)

Serum ferritin (μg/L)

G6PD (%)

Mean

27.33

9.99

30.48

3.47

89.67

30.45

57.22

Median

28

10.5

33

3.74

90

30

56

Mode

30

11.5

35

4

90

30

40

SD

4.21

2.04

5.21

0.77

1.32

1.14

1.33

Range

15

8

17.5

2.77

84

48

48

Minimum

20

5.5

19.5

2.03

46

10

39

Maximum

35

13.5

37

4.8

130

58

87

SD Standard deviation

Prevalence of anaemia, malaria and G6PD deficiency

Among the 95 pregnant women, 51 were anaemic with a prevalence of 53.7% of which 14 (14.7%) was mild, 30 (31.6%) moderate and 7 (7.4%) severe anaemia. Malaria had a prevalence of 12.6% (12/95) while the prevalence of G6PD deficiency was 60% (57/95).

Association of anaemia with diagnostic parameters

Anaemia was more prominent in pregnant women of the age group between 20 and 29 years than those between 30 and 39 years but there was no significant correlation between age group and anaemia (r 0.231, CI 0.12–0.28, p = 0.166). Anaemia in pregnancy was mostly present in the second trimester, followed by the first trimester, and least in third trimester. Anaemia was not associated with the trimester of pregnancy (r 0.184, CI 0.71–0.87, p = 0.789). Also, the MCV did not correlate with anaemia in pregnancy (r 0.182, 0.25–0.44, p = 0.370). On the other hand, PCV level was associated with anaemia (r 0.875, CI 0.00–0.03, p < 0.05) as most of the women with anaemia had a PCV level below 30%. Similarly, anaemia in pregnancy was associated with RBC count below 3.2 million/mm3 (r 0.679, CI 0.00–0.03, p < 0.05). Results are summarized in Table 2.
Table 2

Demographic characteristics and predictors of anaemia among pregnant women

Variables

Anaemia status

r (95% CI)

p value

Absent (%)

Mild (%)

Moderate (%)

Severe (%)

Total

  

Age range (years)

 20–29

25 (43.1)

10 (17.2)

21 (36.2)

2 (3.4)

58

0.231 (0.12–0.28)

0.166

 30–39

19 (51.4)

4 (10.8)

9 (24.3)

5 (13.5)

37

Trimester

 First

17 (45.9)

7 (18.9)

11 (29.7)

2 (5.4)

37

0.184 (0.71–0.87)

0.789

 Second

14 (40.0)

5 (14.3)

12 (34.3)

4 (11.4)

35

 Third

13 (56.5)

2 (8.7)

7 (30.4)

1 (4.3)

23

MCV (fL/cell)

 80

35 (46.1)

11 (14.5)

26 (34.2)

4 (5.3)

76

0.182 (0.25–0.44)

0.370

 80

9 (47.4)

3 (15.8)

4 (21.1)

3 (15.8)

19

PCV (%)

 30

44 (73.3)

12 (20.0)

4 (6.7)

0 (0.0)

60

0.875 (0.00–0.03)

0.000

 30

0 (0.0)

2 (5.7)

26 (74.3)

7 (20.0)

35

RBC (million/mm3)

 3.2

42 (70.0)

9 (15.0)

7 (11.7)

2 (3.3)

60

0.679 (0.00–0.03)

0.000

 3.2

2 (5.7)

5 (14.3)

23 (65.7)

5 (14.3)

35

r Pearson correlation coefficient; CI confidence interval

Association of anaemia with risk factors (ferritin, malaria and G6PD deficiency)

Low serum ferritin was associated with anaemia in pregnancy (OR 5.500, CI 2.25–13.42, p < 0.05) as anaemia was not usually present when the serum ferritin level was above 30 µg/L, while it was mostly present when serum ferritin level was below 30 µg/L. G6PD deficiency correlated with anaemia in pregnancy (OR 0.087, CI 0.03–0.23, p < 0.05). There was little or no association between malaria and anaemia in pregnant women (OR 1.184, CI 0.35–3.97, p = 0.964). The results are summarized in Table 3.
Table 3

Predictors of anaemia in pregnancy

Variables

Anaemia status

OR (95% CI)

r (95% CI%)

p value

Absent (%)

Mild (%)

Moderate (%)

Severe (%)

Total

   

Ferritin (μg/L)

 30

33 (64.7)

8 (15.7)

7 (13.7)

3 (5.9)

51

5.500 (2.25–13.42)

0.454 (0.00–0.03)

0.00

 30

11 (25.0)

6 (13.6)

23 (52.3)

4 (9.1)

44

G6PD

 Deficient

14 (24.6)

11 (19.3)

26 (45.6)

6 (10.5)

57

0.087 (0.03–0.23)

0.537 (0.00–0.03)

0.00

 Non-Deficient

30 (78.9)

3 (7.9)

4 (10.5)

1 (2.6)

38

Malaria

 Present

6 (50.0)

2 (16.7)

3 (25.0)

1 (8.3)

12

1.184 (0.35–3.97)

0.054 (0.93–1.00)

0.964

 Absent

38 (45.8)

12 (14.5)

27 (32.5)

6 (7.2)

83

r correlation coefficient, CI confidence interval, OR: odd ratio

Discussion

Anaemia in pregnancy remains a problem of public health concern especially in developing countries where it can lead to so many adverse conditions or consequences which can affect the productivity and reproductive capacity of women and also lead to maternal death [18]. The prevalence of anaemia in pregnancy was 53.7% of which moderate anaemia was the most prevalent (31.6%) while severe anaemia was the least (7.4%). This results fall within the range of previous data reported in developing countries which showed the prevalence of anaemia in pregnancy to range from 35.0 to 75.0% [19]. Also, previous studies in Nigeria [2022], Ghana [23] and South East Africa [2426] have shown the prevalence of anaemia to be in a close range to that found in this study.

One of the main contributing risk factors of anaemia is iron deficiency which accounts for about 50% of all cases of anaemia [27]. Serum ferritin has been used as a measure for iron deficiency since it serves as iron store in the body [28]. Malaria in pregnancy has also been shown to be characterized by secondary anaemia which is at risk to mother and off-spring [29]. This is as a result of malaria parasite that destroys erythrocytes during cell division and merozoite release [30]. Another risk factor of anaemia is G6PD deficiency whereby a deficiency in this enzyme makes erythrocytes to be vulnerable to oxidative damage hence, liable to haemolysis and eventually anaemia [31]. The evaluation of these parameters for association with anaemia showed low serum ferritin (OR 5.5) and G6PD deficiency (OR 0.087) as high risk factor of anaemia. Thus, low serum ferritin or iron deficiency is found to be the most prevalent risk factor of anaemia. This has been confirmed in other studies which have shown iron deficiency to be responsible for anaemia [32] and iron supplementation as a protective measure [33, 34]. G6PD deficiency which had a prevalence of 60% was also shown to be associated with anaemia. This confirms previous studies which have earlier shown this relationship [35, 36]. However, malaria which had a prevalence of 12.6% showed little or no association (OR 1.184) with anaemia in pregnancy and thus not a potential risk factor. This is in contrast to the findings of a study by Matangila and collaborators which showed asymptomatic Plasmodium falciparum infection with a prevalence of about 30% to be associated with anaemia in pregnancy [37]. It is possible that seasonal variation may have accounted for this difference in malaria prevalence as this present study was carried out between April and May, a period whereby the rainy season was at an early stage in Nigeria compared to the study of Matangila and collaborators which was conducted from July to August deep into the rainy season where malaria transmission was at its peak accounting for the high prevalence and hence association with anaemia. The low prevalence of malaria observed in this study was hence a positive factor that minimized the extent of pregnancy associated anaemia as the presence of malaria is a known predictor of anaemia [38].

In conclusion, anaemia was found highly prevalent in pregnant women attending antenatal care at Prime Care Hospital in Trans-Ekulu region of Enugu Nigeria and was strongly associated with low serum ferritin level and G6PD deficiency as potential risk factors.

Limitations

This study is a pilot study and was focused on one hospital, thus the small sample size may be limiting to generalize the findings to a large geographic area. Also, the study was carried out between April and May, a period during the rainy season where malaria transmission is not at its peak, thus low prevalence of malaria.

Abbreviations

WHO: 

World Health Organisation

Hb: 

haemoglobin

G6PD: 

glucose 6 phosphate dehydrogenase

GSH: 

reduced glutathione

RBC: 

red blood cell

MCV: 

mean cell volume

PCV: 

pack cell volume

ANC: 

anti-natal care

OR: 

odd ratio

SPSS: 

statistical package for social sciences

CI: 

confidence interval

Declarations

Authors’ contributions

GAE conceived and designed the study along with MU, and AO. GAE carried out the field work and laboratory work along with MU and MNU. WFM, MGCN and GAE were involved in data analysis and interpretation. WFN, AO, MGCN, MNU, KNA and GAE were all involved in drafting the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank the staff of Prime Care Hospital for the care of the participants and their assistance throughout the study.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analysed during this study are included in this published article and its additional files.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study design was reviewed and approved by the Local Ethical Institutional Review Board of the Department of Biological Sciences, Godfrey Okoye University, Enugu, Nigeria. Written informed consent was obtained from all pregnant women willing to participant in the study.

Funding

GAE is grateful to Rev. Fr. Prof. Christian Anieke, the Vice Chancellor of Godfrey Okoye University Enugu and the South Africa Medical Research Council for financial support.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Biochemistry, Department of Chemical Sciences, Faculty of Natural and Applied Sciences, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria
(2)
Department of Microbiology, Faculty of Natural and Applied Sciences, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria
(3)
Department of Sociology/Psychology, Faculty of Social and Management Sciences, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria
(4)
Department of Biochemistry, Ebonyi State University, P.M.B. 053, Abakaliki, Nigeria
(5)
Laboratory for Public Health Research Biotechnologies, The Biotechnology Centre, University of Yaounde I, BP 8094, Yaounde, Cameroon
(6)
SAMRC Microbial Water Quality Monitoring Centre, Department of Biochemistry and Microbiology, University of Fort Hare, Alice, South Africa

References

  1. Balarajan Y, Ramakrishnan U, Ozaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and middle-income countries. Lancet. 2011;378:2123–35.View ArticlePubMedGoogle Scholar
  2. WHO. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.Google Scholar
  3. WHO. Worldwide prevalence of anaemia 1993–2005. WHO global database on anaemia. Geneva: World Health Organisation; 2005.Google Scholar
  4. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013;1:E16–25.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Tolentino K, Friedman JF. An update on anaemia in less developed countries. Am J Trop Med Hyg. 2007;77:44–51.PubMedGoogle Scholar
  6. Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr. 2000;71:1285S–7S.PubMedGoogle Scholar
  7. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001;131:568S–79S.PubMedGoogle Scholar
  8. Worwood M. Ferritin in human tissues and serum. Clin Haematol. 1982;11:275–307.PubMedGoogle Scholar
  9. Ogilvie C, Fitzsimons K, Fitzsimons E. Serum ferritin values in primary care: are high values overlooked. J Clin Pathol. 2010;63:1124–6.View ArticlePubMedGoogle Scholar
  10. Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono A, Luzzatto L. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood. 2012;120:4123–33.View ArticlePubMedGoogle Scholar
  11. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol. 2004;20:425–32.View ArticlePubMedGoogle Scholar
  12. Seidman DS, Shiloh M, Stevenson DK, Vreman HJ, Gale R. Role of hemolysis in neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 1995;127:804–6.View ArticlePubMedGoogle Scholar
  13. Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono A, Luzzatto L. Clinical spectrum and severity of hemolytic anemia in glucose 6- phosphate dehydrogenase-deficient children receiving dapsone. Blood. 2012;120:4123–33.View ArticlePubMedGoogle Scholar
  14. Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol. 2009;2:186–92.PubMedPubMed CentralGoogle Scholar
  15. Agan T, Ekabua J, Udoh A, Ekanem E, Efiok E, Mgbekem M. Prevalence of anemia in women with asymptomatic malaria parasitemia at first antenatal care visit at the University of Calabar Teaching Hospital, Calabar, Nigeria. Int J Womens Health. 2010;2:229–33.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Worwood M, et al. Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. Br J Haematol. 1980;46:409–16.View ArticlePubMedGoogle Scholar
  17. Brewer GJ, Tarlov AR, Alving AS. Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity. Bull World Health Organ. 1960;22:633–40.PubMedPubMed CentralGoogle Scholar
  18. Haas JD, Brownlie TT. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131:676S–88S.PubMedGoogle Scholar
  19. Omigbodun AO. Recent trends in the management of anaemia in pregnancy. Trop J Obstet Gynaecol. 2004;21(1):1–3.Google Scholar
  20. Olatunbosun OA, Abasiattai AM, Bassey EA, James RS, Ibanga G, Anyiekere M. Prevalence of anaemia among pregnant women at booking in the University of Uyo Teaching Hospital, Uyo, Nigeria. BioMed Res Int. 2014. https://doi.org/10.1155/2014/849080.PubMedPubMed CentralGoogle Scholar
  21. Adinma JI, Ikechebelu JI, Onyejimbe UN, Amilo G, Adinma E. Influence of antenatal care on the haematocrit value of pregnant Nigerian Igbo women. Trop J Obstet Gynaecol. 2002;19:68–70.Google Scholar
  22. Idowu OA, Mafiana CF, Sotiloye D. Anaemia in pregnancy: a survey of pregnant women in Abeokuta, Nigeria. Afr Health Sci. 2005;5(4):295–9.PubMedPubMed CentralGoogle Scholar
  23. Geelhoed D, Agadzi F, Visser L, et al. Severe anemia in pregnancy in rural Ghana: a case-control study of causes and management. Acta Obstet Gynecol Scand. 2006;85:1165–71.View ArticlePubMedGoogle Scholar
  24. Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr. 2000;72:S247–56.Google Scholar
  25. Hogue M, Kader SB, Hogue E. Prevalence of anaemia in pregnancy in the Uthungulu health district of KwaZulu-Natal, South Africa. S Afr Fam Pract. 2007;49:16–22.View ArticleGoogle Scholar
  26. Hogue AK, Kadar SB, Hogue E, Mugero C. Prevalence of anaemia in pregnancy at Greytown, South Africa. Trop J Obstet Gynaecol. 2006;23:3–7.Google Scholar
  27. WHO/UNICEF/UNU. Iron deficiency anaemia: assessment, prevention, and control. Geneva: World Health Organization; 2001.Google Scholar
  28. Gordeuk VR, Reboussin DM, McLaren CE, Barton JC, Acton RT, McLaren GD, Harris EL, Reiss JA, Adams PC, Speechley M, Phatak PD, Sholinsky P, Eckfeldt JH, Chen WP, Passmore L, Dawkins FW. Serum ferritin concentrations and body iron stores in a multiethnic primary care population. Am J Haematol. 2008;83:618–26.View ArticleGoogle Scholar
  29. Menendez C, Fleming AF, Alonso PL. Malaria-related anaemia. Parasitol Today. 2000;16:469–76.View ArticlePubMedGoogle Scholar
  30. Phillips RE, Pasvol G. Anaemia of Plasmodium falciparum malaria. Epidemiol Haematol Dis. 1992;5:315–30.Google Scholar
  31. Beutler E. G6PD deficiency. Blood. 1994;84:3613–36.PubMedGoogle Scholar
  32. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. J Am Med Assoc. 1997;277:973–6.View ArticleGoogle Scholar
  33. Menendez C, Kahigwa E, Hirt R, et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet. 1997;350:844–50.View ArticlePubMedGoogle Scholar
  34. Menendez C, Todd J, Alonso PL, et al. The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg. 1994;88:590–3.View ArticlePubMedGoogle Scholar
  35. Akanni EO, Oseni BS, Agbona VO, Tijani BA, Tosan E, Fakunle EE, Mabayoje VO. Glucose-6-phosphate dehydrogenase deficiency in blood donors and jaundiced neonates in Osogbo, Nigeria. J Med Lab Diagn. 2010;1:1–4.Google Scholar
  36. Kaplan M, Hemmerman C. Severe neonatal hyper-bilirubinemia: A potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol. 1998;25:575–90.PubMedGoogle Scholar
  37. Matangila JR, Lufuluabo J, Ibalanky AL, Luz RA, Lutumba P, Geertruyden JP. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo. Malar J. 2014;13:132–9.View ArticlePubMedPubMed CentralGoogle Scholar
  38. UNDP, WB, WHO. The prevention and management of severe anaemia in children in malaria-endemic regions of Africa: a review of research. Geneva: World Health Organisation; 2001.Google Scholar

Copyright

© The Author(s) 2017

Advertisement